 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis |
| Hyuk Yoon |
|
Intest Res. 2019;17(3):283-284. Published online July 25, 2019 DOI: https://doi.org/10.5217/ir.2019.00070 |
|
Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis Intestinal Research. 2019;17(3):283-284  Exam 1: Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis and Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis Gastroenterology. 2014;146(1):e14-e15 Biologics for the treatment of moderate- to-severe ulcerative colitis in pediatric patients Pediatric Health, Medicine and Therapeutics. 2012;51 Severe ulcerative colitis Current Treatment Options in Gastroenterology. 1999;2(2):113-118 Biologic Therapy in Moderate-to-Severe Ulcerative Colitis: Infliximab Crohn's Disease and Ulcerative Colitis. 2017;429-433 Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab Therapeutics and Clinical Risk Management. 2013;451 Su1827 - Markers of Systemic Inflammation in Moderate-Severe Ulcerative Colitis: What Level of C-Reactive Protein Constitutes Acute Severe Ulcerative Colitis? Gastroenterology. 2018;154(6):S-598 Cost-Utility Analysis of Adalimumab for The Treatment of Moderate-To-Severe Ulcerative Colitis In Patients In Spain Value in Health. 2015;18(7):A670 Mo1325 Cost-Effectiveness of Infliximab Scheduled Maintenance Treatment for the Management of Patients With Moderate-to-Severe Ulcerative Colitis Gastroenterology. 2013;144(5):S-637 Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis Journal of Crohn's and Colitis. 2014;8(7):571-581 |
